Cargando…

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer()

MicroRNAs (miRNAs) are short single-stranded RNAs, measuring 21 to 23 nucleotides in length and regulate gene expression at the post-transcriptional level through mRNA destabilization or repressing protein synthesis. Dysregulation of miRNAs can lead to tumorigenesis through changes in regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vo, Dat T., Karanam, Narasimha Kumar, Ding, Lianghao, Saha, Debabrata, Yordy, John S., Giri, Uma, Heymach, John V., Story, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642270/ https://www.ncbi.nlm.nih.gov/pubmed/31325708 http://dx.doi.org/10.1016/j.neo.2019.06.004

Ejemplares similares

Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
por: Karanam, Narasimha Kumar, et al.
Publicado: (2017)

Evaluation of the Response of HNSCC Cell Lines to γ-Rays and (12)C Ions: Can Radioresistant Tumors Be Identified and Selected for (12)C Ion Radiotherapy?
por: Ding, Lianghao, et al.
Publicado: (2022)

Assessment and topographic characterization of locoregional recurrences in head and neck tumours
por: Ferreira, Brigida Costa, et al.
Publicado: (2015)

Blasted Cell Line Names
por: Wang, Jing, et al.
Publicado: (2010)

Cutaneous Angiosarcoma of Head and Neck: A New Predictive Score for Locoregional Metastasis()()
por: Gründahl, J.E.H., et al.
Publicado: (2015)

Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies
por: Gao, Jing, et al.
Publicado: (2019)

Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control
por: Hahn, Ezra, et al.
Publicado: (2022)

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Persistent Post-radiotherapy Pain and Locoregional Recurrence in Head and Neck Cancer-Is There a Hidden Link?
por: Srivastava, Preety, et al.
Publicado: (2015)

Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
por: Bonner, James A., et al.
Publicado: (2019)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer
por: Bhide, S A, et al.
Publicado: (2008)

Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer
por: Bruixola, Gema, et al.
Publicado: (2018)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
por: Szturz, Petr, et al.
Publicado: (2019)

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes
por: Chang, Jer-Hwa, et al.
Publicado: (2017)

The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial
por: Botticelli, Andrea, et al.
Publicado: (2020)

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
por: Saddawi-Konefka, Robert, et al.
Publicado: (2021)

Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients
por: Zaboli, David, et al.
Publicado: (2012)

HOPX functions as a tumour suppressor in head and neck cancer
por: Yap, Lee Fah, et al.
Publicado: (2016)

The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
por: Fritsche, Marie Kristin, et al.
Publicado: (2017)

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
por: Qin, Lei, et al.
Publicado: (2018)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
por: Chen, Tien-Hua, et al.
Publicado: (2022)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials
por: Kim, Bum Jun, et al.
Publicado: (2017)

Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis
por: Melariri, Herbert, et al.
Publicado: (2023)

CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers
por: Jiang, Yu L, et al.
Publicado: (2010)

MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023)

Efficacy of Iodine-125 Seed Implantation in Locoregionally Recurrent and Unresectable Breast Cancer: a Retrospective Study
por: Yu, Ying-hua, et al.
Publicado: (2017)

Intensity‐modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital
por: Rumley, Christopher N., et al.
Publicado: (2016)

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
por: Aggarwal, Himani, et al.
Publicado: (2020)

Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy
por: Bojaxhiu, Beat, et al.
Publicado: (2020)

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Treatment of malignant rhabdoid tumors of the head and neck with combined chemotherapy and (125)I particle implantation
por: Duan, Chao, et al.
Publicado: (2018)

Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma
por: Lemaire, F, et al.
Publicado: (2004)

Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
por: Cognetti, David M., et al.
Publicado: (2021)

Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma
por: Ye, Jing, et al.
Publicado: (2020)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer
por: Casarotto, Mariateresa, et al.
Publicado: (2022)

Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wu, Chunrong, et al.
Publicado: (2020)

Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer
por: Yan, Bin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_obi7ngft16jg54jfvqf0fud1oc